Public Release:  Forum to bring together leading-edge ophthalmic researchers and investors

Sessions will explore early-stage opportunities

Association for Research in Vision and Ophthalmology

Rockville, Md . - The newest ophthalmic innovations with market potential will be the focus of a one-day seminar in Seattle on May 3, 2013 that will connect scientists, venture capitalists, pharmaceutical representatives and others. Unlike other investor forums, the meeting will focus on cutting-edge research, rather than established companies.

The event aims to help innovators and scientists better understand how products move through the approval and commercialization pipeline, while giving investors insight into treatments and devices that are nearing readiness for commercial development.

The Vision Innovation and Venture Forum is being organized by the ARVO Foundation for Eye Research. ARVO (Association for Research in Vision and Ophthalmology) is the world's largest organization of eye and vision scientists.

"Modern science and industry have made tremendous progress in preventing and treating eye disease," explains Foundation Chair Nicholas Bazan, MD, PhD, "but there is still a great need to develop more effective treatments and devices to help alleviate these conditions. Many areas of ophthalmic science require additional research support -- and they offer opportunities for commercial development.

"The Foundation's Innovation Forum will provide a unique opportunity for private equity managers, venture capitalists, analysts and others to assess the value of emerging treatments through an independent scientific and commercial lens. They will also join in discussion with the scientists and commercial experts who are working at the cutting edge of these fields."

The program features keynote speaker Mark S. Blumenkranz, MD, MMS, of Stanford University, who was an early innovator in vitrectomy techniques to treat complex forms of retinal detachment, and who helped usher in the modern era of intravitreal and surgical adjuvant drug therapy.

The program also features ample networking opportunities and showcases of promising research, as well as lunch and a concluding reception.

Complete program, venue and registration information is available at www.arvofoundation.org/visionforum.

###

The Association for Research and Vision in Ophthalmology (ARVO) is the largest eye and vision research organization in the world. Members include more than 12,500 eye and vision researchers from over 80 countries. ARVO encourages and assists research, training, publication and knowledge-sharing in vision and ophthalmology.

The ARVO Foundation for Eye Research complements ARVO's mission to further global eye and vision research by:

  • Promoting scientific interactions and exchange
  • Fostering translational research and moving forward scientific breakthroughs from the laboratory to clinical practice
  • Recruiting and retaining scientists in all fields of vision research

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.